Clinical Evidence

Lipogems® is a new and innovative treatment that has helped over 35,000 patients worldwide. It has been extensively researched, please see some of the key clinical papers below for more information.

PRP therapy is an effective and well researched treatment. It has been widely used in sport injuries as well as in aesthetic medicine. To find out more, please see the clinical evidence below.

To see how the treatment could help you make an appointment our multidisciplinary team or call 0330 2233332 for more information.

Dr. Mikel Sánchez explains how his recent study supports the safety and efficacy of PRP for pain relief and improved function in patients with osteoarthritis in the hip.

Read the full clinical paper

Dr. Konrad Slynarski speaks to the Regenerative Clinic about his extensive experience using micro-fragmented adipose tissue stem cells in joint preservation and three year clinical studies in the field.

Clinical Papers

A 24-Month Follow-Up Study of the Effect of Intra-Articular Injection of Autologous Microfragmented Fat Tissue on Proteoglycan Synthesis in Patients with Knee Osteoarthritis

The Regenerative Clinic’s view on this research

This paper published in December 2019, reports on patients with advanced knee arthritis treated with Micro-fragmented Fat. The patients were monitored over a 24-month period. Their pain and function were recorded; and all had an MRI scan immediately before the treatment and 24 months after.

17 patients were enrolled and 10 fulfilled the criteria for follow-up. Three had a joint replacement and 4 were lost to follow-up. All of the 10 patients followed-up at 24 months showed a significant reduction in pain and an overall notable increase in the volume of cartilage measured on the contrast-enhanced MRI scan.

This study demonstrates a degree of regeneration of the cartilage which is associated with pain relief in a significant proportion of patients who had a single injection of micro-fragmented fat for knee arthritis.

Abstract Osteoarthritis (OA) is a widely prevalent disease worldwide, and with an increasingly ageing society, it has become a challenge for the field of regenerative medicine. OA is a disease process involving multiple j…

Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients

The Regenerative Clinic’s view on this research

Mr Ali Noorani “A further study in hip arthritis with femoral head osteonecrosis was published in 2018. The study included a total of 125 patient in bilateral hip osteonecrosis. The results are very interesting, this was a 30 year follow up of perspective randomised study of a large number of patients. These patients who had bilateral osteonecrosis i.e both hips are affected, the larger lesions were treated with BMAC and the smaller lesions were treated with just decompression. Overall, the results of bone marrow were clearly superior. Only 28% of the bone marrow group collapsed compared to 72% of the decompression group. In addition, only 24% of the patients had total hip replacement compared to 76% of just the decompression group.”

Abstract PURPOSE: Symptomatic osteonecrosis related to corticosteroids has a high risk of progression to collapse in absence of treatment. The purposes of this study were to evaluate the results of autologous bone marrow…

Clinical Outcomes of Knee Osteoarthritis Treated With an Autologous Protein Solution Injection: A 1-Year Pilot Double-Blinded Randomized Controlled Trial

The Regenerative Clinic’s view on this research

In this randomized, blinded study of 46 patients, 31 suffering with grade 2-3 osteoarthritis received ultrasound guided knee injections of an autologous protein solution (APS) derived from the nSTRIDE kit, which uses centrifugation to concentrate platelets, growth factors and anti-inflammatory cytokines from the blood. The other 15 received an injection of saline. Analysis after 12 months showed an excellent safety profile and a significant improvement in the WOMAC pain score (65% of patients) compared with the saline-treated controls (41%). The results support other published findings indicating a protective/pain relieving effect of APS that could benefit people with chronic moderate knee arthritis, with effects lasting for a year or more.

Abstract BACKGROUND: Osteoarthritis (OA) is a debilitating disease resulting in substantial pain and functional limitations. A novel blood derivative has been developed to concentrate both growth factors and antagonists …

Autologous micro-fragmented adipose tissue for the treatment of diabetic foot minor amputations: a randomized controlled single-center clinical trial (MiFrAADiF)

The Regenerative Clinic’s view on this research

In this randomised clinical trial 57 patients with diabetes-related non-healing ulcers of the foot were treated with micro-fragmented adipose tissue (MFAT) injections, obtain. ed using the Lipogems system, at the injury site following forefoot or toe amputation. A further 57 patients were treated only with the gold standard conventional therapy following similar amputations. After 6 months, only 46% of the control group showed a fully healed wound whilst 80% of the Lipogems treated group recovered. No adverse events were recorded in the Lipogems treatment cohort. This study indicates that MFAT may have a valuable clinical application in supporting the safe natural and effective repair of complex or difficult to heal wounds.

Abstract Background: The diabetic foot ulcer (DFU) is one of the most prevalent complications of diabetes mellitus and often develops severe effects that can lead to amputation. A non-healing “minor” amputation often…

Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: a case-controlled study

The Regenerative Clinic’s view on this research

Mr Ali Noorani “A study on rotator cuff tears was carried out and published in 2014. This is a case-controlled study with level 3 data. The patients were divided into two groups, one that received mesenchymal stem cells from bone marrow aspirate during arthroscopy and the other group that just had the arthroscopy. There was a total of 45 patients in each group and the rotator cuff tear sizes were between 1.4-2.5cm. In this study, when bone marrow aspirate was injected, a total of 150CCs of aspiration was carried out delivering 51,000 MSCs (4,300 CFU/ml) 8CC was injected into the greater tuberosity and 4CC at the repair site. The patients were followed up for 10 years and they had MRIs post operatively at 3 months, 6 months, 1 year, 2 years and at the most recent follow up (minimum 10 years). 100% of the patients in the bone marrow group had healed at 6 months versus 67% of the patients treated without bone marrow. At the 10 year follow up, in the bone marrow group 87% of the patients still had intact rotator cuffs whereas those who did not receive bone marrow treatment only 44% had intact rotator cuffs in the MRI scan. The study concluded that bone marrow aspirate MSCs was the most important variable in determining outcomes in these groups of patients.”

Abstract PURPOSE: The purpose of this study was to evaluate the efficiency of biologic augmentation of rotator cuff repair with iliac crest bone marrow-derived mesenchymal stem cells (MSCs). The prevalence of healing and…

Lateral epicondylitis: a review of pathology and management

The Regenerative Clinic’s view on this research

A more recent study by Ahmad et al 10 looked at the use of PRP injections versus extra corporeal shock-wave therapy for chronic lateral epicondylitis. This study had a minimum of a 2 years follow up was a retrospective comparison study and concluded that both PRP injections and extra corporeal shock-wave therapy are safe options for treatment for chronic lateral epicondylitis and there is low risk of complications and with good long-term follow up results. However, they did note that ultrasound guided PRP injections was quicker in achieving symptom resolution. The mean time to return to active normal life was also quicker with PRP when compared to shockwave therapy.

Abstract Lateral epicondylitis, or ‘tennis elbow’, is a common condition that usually affects patients between 35 and 55 years of age. It is generally self-limiting, but in some patients it may continue to cause persiste…

Role of Inflammation and the Immune System in the Progression of Osteoarthritis

Abstract Understanding the molecular drivers and feedback loops of osteoarthritis (OA) may provide future therapeutic strategies to modulate the disease progression. The current paradigm of OA is evolving from a purely m…

Autologous Interleukin 1 Receptor Antagonist Blood-Derived Products for Knee Osteoarthritis: A Systematic Review.

Abstract PURPOSE: To systematically review the available clinical data regarding the use of autologous IL-1 receptor antagonist blood products (AILBPs) and their validity as an alternative intra-articular (IA) therapy fo…

Innovative regenerative medicine in the management of knee OA: The role of Autologous Protein Solution

Abstract Osteoarthritis (OA) is one of the most common causes of chronic disability in adults due to pain and altered joint function. Although most patients report pain and functional limitation, symptoms, age of onset a…

Role of White Blood Cells in Blood- and Bone Marrow-Based Autologous Therapies

Abstract There has been significant debate over the role of white blood cells (WBCs) in autologous therapies, with several groups suggesting that WBCs are purely inflammatory. Misconceptions in the practice of biologic o…

Get in touch

Find your clinic

We offer appointments nationwide and now working with partners abroad providing cutting edge Regenerative Medicine to patients in Dubai, Australia, Spain and Pakistan.

Sign-up to receive our recent news and the latest developments in regenerative medicine.

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at info@theregenerativeclinic.co.uk. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.